Chromosome 5q deletion is extremely rare in patients with myelofibrosis
about
Thalidomide treatment in a myelofibrosis patient with leukemia transformation.Myelodysplastic disorders carrying both isolated del(5q) and JAK2(V617F) mutation: concise review, with focus on lenalidomide therapyClinical characteristics and outcomes of therapy-related chronic myelomonocytic leukemia.Myelofibrosis: an update on drug therapy in 2016.Management of myelofibrosis: JAK inhibition and beyond.Acute lymphoblastic leukemia secondary to myeloproliferative neoplasms or after lenalidomide exposure.
P2860
Chromosome 5q deletion is extremely rare in patients with myelofibrosis
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Chromosome 5q deletion is extremely rare in patients with myelofibrosis
@ast
Chromosome 5q deletion is extremely rare in patients with myelofibrosis
@en
type
label
Chromosome 5q deletion is extremely rare in patients with myelofibrosis
@ast
Chromosome 5q deletion is extremely rare in patients with myelofibrosis
@en
prefLabel
Chromosome 5q deletion is extremely rare in patients with myelofibrosis
@ast
Chromosome 5q deletion is extremely rare in patients with myelofibrosis
@en
P2860
P50
P1433
P1476
Chromosome 5q deletion is extremely rare in patients with myelofibrosis
@en
P2093
Koichi Takahashi
Lynne Abruzzo
P2860
P304
P356
10.1016/J.LEUKRES.2013.01.003
P577
2013-02-04T00:00:00Z